RE: Partner, one of four?1 Nov 2019 13:04
Bristol-Myers Squibb is the only pharma with a PD 1 inhibitor that targets colorectal cancer.
so joining the dots,
1] a USA based pharma with a unique drug, only one in the world with clevegen working together.
2] FARN expanding trials in the USA seeking FDA permissions
3] Partner discussing ongoing but every time our CEO says clevegen could be a standalone treatment and also a combination treatment